when switching from semaglutide to tirzepatide Switching from semaglutide to tirzepatide
Description
Women with PCOS often find it difficult to maintain a healthy weight due to hormonal imbalances and insulin resistance
It begins November 1 and ends January 15
Same-day consultations available.
Food and Drug Administration (FDA) and is only available with a prescription from a healthcare provider
Usually used under medical supervision
Amongst, overweight and obese patients defined by BMI in 2024 (58.9% [95% CIs 53.3-64.2%] female [182/309], median [IQR] age 56.6 [46.2-66.1]) GLP 1RA use has increased from 3.2% (10/309 [95% CIs 1.8-5.9%]) to 13.6% (42/309 [95% CIs 10.2-17.9%] [p=7.1x10-6])
